Comprehensive Climate Compliance Services for Pharmaceutical Suppliers
Meet new supply chain reporting requirements for Big Pharma with expert verification, validation and consulting services from SCS.
In a joint letter signed on July 20, 2023, seven of the world’s pharmaceutical giants, including AstraZeneca, GSK, Novo Nordisk, Merck, Roche, Sanofi and Samsung Biologics, published an open letter to their suppliers outlining new supply chain requirements to accelerate the transition to net zero in the healthcare sector. The company’s leaders have set joint, minimum climate and sustainability targets. Beginning in 2025 suppliers will need to disclose emissions across all three scopes and commit to near term targets through the Science Based Target initiative (SBTi). Suppliers will need to switch to at least 80% renewable power by 2030. ; Suppliers will also need to set targets to reduce waste, increase water efficiency and establish water stewardship practices. to switching to renewable power and renewable heat by 2030; and commitments to setting standards for suppliers’ own supply chains and setting targets to.
SCS offers pharma suppliers a comprehensive range of services for strategic implementation, verification, and consulting to assess, calculate and report on Scopes 1, 2 and 3 emissions, verify and assure sustainability report data, create successful sustainability reports using leading reporting frameworks including CDP, SASB, TFND, GRI and others, set science-based targets, implement water stewardship practices, and establish successful sustainability programs for internal and external supply chains.